Forecast: Three Impressive Shares anticipated to surpass Palantir's value by 2028

Forecast: Remarkable Shares Set to Surpass Palantir's Value by 2028

In the dynamic world of global business, two distinct sectors stand out: technology and healthcare. This article offers an insightful comparison between Alibaba, a leading Chinese technology company and cloud-services provider, and UnitedHealth Group, a prominent American healthcare company. We'll also delve into the unique trajectories of ASML, a Dutch semiconductor fabrication-equipment company, and Palantir Technologies, an American data-analytics firm.

Alibaba and UnitedHealth Group: A Side-by-Side Comparison

Alibaba, with a market cap of approximately $282 billion, is one of the top developers of AI technology in China. The company, which boasts a forward price-to-earnings (P/E) ratio of 13.8, is expected to have an accelerated growth going forward. In contrast, UnitedHealth Group, whose market cap topped $500 billion as recently as April, trades at the lowest earnings multiples in more than a decade. The company's shares have been under pressure due to higher-than-anticipated medical costs, particularly those related to Medicare Advantage plans.

The U.S. Department of Justice is conducting civil and criminal investigations into UnitedHealth's Medicare billing practices, adding to the company's challenges. However, billionaires Warren Buffett and David Tepper aggressively bought UnitedHealth Group stock in the second quarter of 2025, indicating a vote of confidence from the investment community.

ASML and Palantir Technologies: A Look at Their Business Models

ASML, a Dutch semiconductor fabrication-equipment company, is a key player in the global semiconductor industry. The company, which trades at roughly 26.7 times forward earnings, commands a near monopoly in extreme ultraviolet lithography (EUV). ASML's PEG ratio (based on five-year earnings growth projections) is 1.51, suggesting that the company is undervalued relative to its growth prospects.

Palantir Technologies, on the other hand, is an American data-analytics firm with a market cap of approximately $370 billion. The company's forward P/E ratio is a staggering 244, while its PEG ratio stands at 4.12, indicating that the market may be pricing in high growth expectations.

Interestingly, the author predicts that three companies will be worth more than Palantir Technologies by 2028, but the specific companies were not specified in the provided documents.

China's Ambitions and Global Dominance

China is determined to be a leader in AI, and Alibaba, as one of its top developers, is well-positioned to contribute to this goal. The company's AI capabilities, combined with its leadership in cloud services, position it for continued growth and success in the years ahead.

In conclusion, while each of these companies operates in distinct sectors and has unique business models, they all share a common thread: the potential for significant growth and continued dominance in their respective fields. Whether it's Alibaba's AI capabilities, UnitedHealth Group's healthcare offerings, ASML's semiconductor equipment, or Palantir's data analytics, these companies are shaping the future of their industries.